Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Cannabis company comeback, Cann Group’s busy few months
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Cannabis company comeback, Cann Group’s busy few months
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Cannabis company comeback, Cann Group’s busy few months
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Cannabis company comeback, Cann Group’s busy few months
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Cannabis company comeback, Cann Group’s busy few months
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • Cann Group poised for growth as demand for locally produced cannabis surges
    Cann Group poised for growth as demand for locally produced cannabis surges
    • News

  • Cann Group strengthens position with variation agreement in medicinal cannabis sector
    Cann Group strengthens position with variation agreement in medicinal cannabis sector
    • News

  • Cannabis company comeback, Cann Group’s busy few months
    Cannabis company comeback, Cann Group’s busy few months
    • News

  • Cann’d: clinical trials show no difference between cannabis capsules and placebo
    Cann’d: clinical trials show no difference between cannabis capsules and placebo
    • News

  • Airtasker locks in purchase agreement with OneFlare
    Airtasker locks in purchase agreement with OneFlare
    • News

  • Finland’s focus on child cyber safety secures Spacetalk with Nordic smartwatch distribution
    • News

    Finland’s focus on child cyber safety secures Spacetalk with Nordic smartwatch distribution

    Increasing prevalence of dark corners on the internet has prompted the nation of Finland to increase child cybersecurity awareness in the Nordic region with tech company Spacetalk (ASX: SPA) one of the beneficiaries, securing national distribution of their smartwatches via telecommunications giant Elisa Corporation.  The deal will see the Spacetalk Adventurer stocked across all of

    Read More
    Public
  • Race Oncology gains more patents for their cancer drug, Zantrene
    • News

    Race Oncology gains more patents for their cancer drug, Zantrene

    The field of cancer research is certainly buzzing with key research yielding new medications with the ultimate goal of improving patient outcomes.  The mind numbingly broad list of diseases and disease subtypes that fall under the ‘cancer’ banner might make it seem like little to no progress is being made in conquering cancer. Look a

    Read More
    Public
  • Revolutionary cancer drug approved to commence Phase 2 clinical trials
    • News

    Revolutionary cancer drug approved to commence Phase 2 clinical trials

    Clinical stage drug development company Pharmaxis (ASX: PXS) is one step closer to seeing their revolutionary cancer drug reach commercialisation. PXS-5505, the Company’s lead asset has received the go-ahead from the safety committee to begin Phase 2 trials following positive results from the Phase 1c study which saw patients with myelofibrosis treated for 28 days

    Read More
    Public
  • FBR homebuilding robot lands $500k contract to construct 8 townhouses
    • News

    FBR homebuilding robot lands $500k contract to construct 8 townhouses

    Construction companies, beware the name Hadrian because his (maybe her?) rising popularity has secured robotics company FBR (ASX: FBR) for the construction of 8 townhouses in Western Australia. The deal is FBR’s first multi-home Wall as a Service™ contract where they will deploy their Hadrian X® construction robot to a residential development site in St

    Read More
    Public
  • Could the milkman make a comeback? A case for reusables in food packaging
    • News

    Could the milkman make a comeback? A case for reusables in food packaging

    Admittedly, the days of the milk man visiting, clanging glass bottles were well before my time. That being said, there’s something so wholesome and quaint about freshly delivered milk and bread in the morning. For those of a similar vintage to myself, here’s what would happen- the night prior to your milk delivery you’d leave

    Read More
    Public
  • Healthia eyes New Zealand expansion as Directors buy up $2.85m of shares
    • News

    Healthia eyes New Zealand expansion as Directors buy up $2.85m of shares

    Shareholders of allied health company Healthia (ASX: HLA) will be pleased to see its Board of Directors committing to their expansion plans by opening up their wallets, backing the Company’s upwards trajectory by purchasing a large parcel of shares themselves. This is exactly what Board members Glen Richards, Paul Wilson, Lisa Dalton, and Wesley Coote

    Read More
    Public
  • Nest feathering Aussies propel Nick Scali to acquire Plush after strong pandemic earnings
    • News

    Nest feathering Aussies propel Nick Scali to acquire Plush after strong pandemic earnings

    Cocktails are out, couches are in. Having become a mainstay of Saturday night lockdown plans, many Aussies have opted to upgrade their couch (and living room furniture), a trend serving to benefit furniture and homeware retailers. The niche market has reaped the rewards of Aussies feathering their nests in an effort to turn their space

    Read More
    Public
  • Focus on elite cleaning services lands Millennium two new contracts for Westfield shopping centres
    • News

    Focus on elite cleaning services lands Millennium two new contracts for Westfield shopping centres

    Cleaning and crowd control specialists Millennium Services Group (ASX:MIL) have been given a big boost to their Victorian operations, securing a 5-year extension to continue providing cleaning services to two of the state’s largest shopping centres. The contract extensions have been awarded by Scentre Group (ASX: SCG), the owner and operator of Westfield living centres

    Read More
    Public
  • Prioritising employee wellness, how this fintech is making R&R the new R&D
    • News

    Prioritising employee wellness, how this fintech is making R&R the new R&D

    Organisational and personal development opportunities have largely fallen by the wayside for companies since the pandemic forced workers out of the office and into pyjama pants.  Logistical and technological barriers mean that it isn’t as easy as getting everyone into a room together for scheduled development programs, despite being an important part of business growth. 

    Read More
    Public
  • MSL Solutions acquires OrderMate with backing from top US equity firm
    • News

    MSL Solutions acquires OrderMate with backing from top US equity firm

    Capitalising on the rise of contactless hospitality which has been accelerated by COVID-19, tech company MSL Solutions (ASX: MSL) is expanding its operations with the backing of Taubman Capital to acquire OrderMate and its 2,400 customers that use the mobile ordering platform.  The acquisition expands MSL’s tech suite which has primarily been point-of-sale (POS) products

    Read More
    Public
  • «
  • ‹
  • 218
  • 219
  • 220
  • 221
  • 222
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.